Deltec Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-100,000
Closed -$304K 185
2024
Q4
$304K Buy
+100,000
New +$304K 0.06% 138